Beacon Pointe Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,051
Closed -$208K 1401
2023
Q4
$208K Sell
9,051
-2,569
-22% -$57.5K ﹤0.01% 1211
2023
Q3
$267K Buy
+11,620
New +$295K ﹤0.01% 1120

Other funds holding PRVA

Beacon Pointe Advisors's PRVA Position: Q1 2024 in Review

Beacon Pointe Advisors sold out of Privia Health (PRVA) in Q1 2024, closing a stake of 9,051 shares — an estimated $208K sold.

Beacon Pointe Advisors first reported a position in PRVA in Q3 2023 and held it in 2 quarters. The position peaked at $267K in Q3 2023. 234 funds tracked by Wall St. Rank hold PRVA as of Q1 2024.

  • Beacon Pointe Advisors reported no remaining Privia Health position as of Q1 2024 after selling out during the quarter.
  • Beacon Pointe Advisors sold 9,051 Privia Health shares in Q1 2024, an estimated $208K.
  • Beacon Pointe Advisors first reported a position in Privia Health in Q3 2023 and held it in 2 quarters.
  • Beacon Pointe Advisors's Privia Health position peaked at $267K in Q3 2023.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q1 2024.

Based on Beacon Pointe Advisors's 13F filing for Q1 2024, filed 14 May 2024.